Krebs Biochemicals & Industries Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 8.81 | 7.28 | 4.17 |
| Operating Expense | 7.68 | 6.98 | 6.96 |
| Net Profit | -2.34 | -3.13 | -6.14 |
| Net Profit Margin | -26.56% | -42.99% | -147.24% |
| Earning Per Share | -1.09 | -1.45 | -2.85 |
| EBIDTA | 1.14 | 0.29 | -2.79 |
| Effective Tax Rate | 0% | 0% | -0% |
Particulars
Mar 2026
Revenue8.81
Operating Expense7.68
Net Profit-2.34
Net Profit Margin-26.56
Earning Per Share-1.09
EBIDTA1.14
Effective Tax Rate0
